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infection and associated morbidity and mortality. The regulating 
mechanisms of the homing and migration steps of HSC 
engraftment are poorly understood and understanding these 
processes will increase transplantation success on many levels. 
Accelerated and more complete engraftment will reduce 
morbidity and mortality associated with transplantation, both 
during engraftment and long-term immune recovery.
The only models currently employed to study human HSC 
engraftment are immunocompromised mice transplanted with 
human HSCs, also called ‘humanised’ mice (Tanner et al., 
2014). Although these mouse models informed current stem 
cell transplantation protocols, they involve prolonged harmful 
procedures and it remains difficult to assess and visualise the early 
steps of engraftment due to the opacity of their tissues. Multiple 
mouse strains have been generated to create suitable immuno-
compromised hosts to allow engraftment of a fully developed 
adaptive immune system (Tanner et al., 2014). In most studies, 
additional harmful irradiation regimes are used to prevent early 
rejection of the transplant by the immune system. These immu-
nodepleted mice must be grown to adulthood in order to assess 
engraftment success, usually performed shortly after birth. These 
genetically altered mice live their entire lives undergoing severe 
procedures with high maintenance requirements, since they 
need to be homed in sterile rooms and fed sterile food to avoid 
fatal infection due to defective immunity. Published articles 
test multiple conditions on groups of 5 to 6 mice sacrificed at 
various time points, resulting in an average of 40 mice per 
publication. In 2015, 25 publications used immunocompromised 
mice for HSC transplant studies, representing around 1000 mice 
each year worldwide – all undergoing severe procedures over a 
long period of time. As the demand for stem cell transplantation 
therapy increases, more efficient and less dangerous procedures 
will be demanded, which will require an even higher mouse usage 
to optimise current protocols.
Zebrafish are already established as a successful model to study 
the haematopoietic system, with significant homology with 
mammals (de Jong & Zon, 2005; Gering & Patient, 2005; Kissa 
& Herbomel, 2010; Renshaw & Trede, 2012; Traver et al., 2003; 
White et al., 2008). Imaging of zebrafish transparent embryos 
remains a powerful tool and has been critical to confirm that 
the zebrafish Caudal Haematopoietic Tissue (CHT) is compa-
rable to the mammalian foetal haematopoietic niche (Gering & 
Patient, 2005; Kissa & Herbomel, 2010; Tamplin et al., 2015). 
Xenotransplantation in zebrafish embryos has revealed highly con-
served mechanisms between zebrafish and mammals. Recently, 
murine bone marrow cells were successfully transplanted into 
zebrafish embryos, revealing highly conserved mechanism of hae-
matopoiesis between zebrafish and mammals (Parada-Kusz et al., 
2017). Additionally, CD34 enriched human cells transplanted 
into zebrafish were shown to home to the CHT and respond to 
zebrafish stromal-cell derived factors (Staal et al., 2016).
We propose that transplanting human HSCs into zebrafish larvae, 
before the onset of adaptive immunity, will offer unprece-
dented in vivo opportunities to understand stem cell engraftment 
and help to shift current research towards a 3Rs approach to 
Introduction
Transplantation of healthy haematopoietic stem cells (HSCs) 
is a critical therapy for a wide range of malignant haemato-
logical and non-malignant disorders and immune dysfunction 
(Snowden et al., 2012; Sykes & Nikolic, 2005; Thomas et al., 
1957). In successful stem cell transplantation (SCT), immune 
reconstitution following ablation of native immunity leads to the 
recovery of immune function. Healthy transplanted stem cells 
home to haematopoietic niches in the host and differentiate into 
multi-lineage blood cells, providing the patient with a new immune 
system (Sullivan et al., 2010). Around 2000 people in the UK are 
in need of SCT every year, and as more hospitals are performing 
this high-risk life-saving procedure, there is a growing need in 
improving current protocols. (http://www.anthonynolan.org)
HSCs are collected from: 1) blood harvested from peripheral 
blood by apheresis following mobilisation by G-CSF cytokine 
treatment; 2) umbilical cord blood; or 3) bone marrow from 
donors or patients. HSCs are enriched post-collection by posi-
tive selection for the CD34 stem cell marker. Conditioning or 
myeloablation of the host bone marrow by chemotherapy is 
necessary to ablate malignant or autoreactive immune popula-
tions, adding a considerable risk of infection while engraftment 
occurs. Incomplete or delayed engraftment results in delayed 
immune system recovery, increasing considerably the risk of 
Research highlights
Scientific benefits:
•    Zebraish embryos are transparent and represent a tractable 
system for imaging Zebraish do not develop an adaptive 
immunity for the irst 2 weeks of life, providing a large time 
window to perform xenotransplantation
3Rs benefits:
•    Zebraish larvae can be used to replace mouse models in 
stem cell transplantation research 
•    Use of zebraish larvae also avoids subjecting mice to 
severe irradiation procedures and eliminates the risk of 
contracting fatal infections
Practical benefits:
•    Zebraish are cheaper to raise and host in ish aquariums 
that can hold thousands of animals 
•    A pair of Zebraish produces hundreds of small embryos 
easily transplanted therefore offering the opportunity to 
perform high-throughput experiments
Current applications:
•    Studying the engraftment mechanism of human HSCs 
•    Drug screens to identify new drugs to improve engraftment 
rate of HSCs 
•    Identifying new human HSC markers to improve the rate and 
speed of engraftment
Potential applications:
•    Assessing the viability and eficacy of human HSC grafts 
before transplanting into patient 
•    Replace the use of mouse models during the optimisation 
phase of HSC transplantation protocols
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reduce and refine, and finally replace the usage of mice in HSC 
transplant studies. Here we describe a detailed transplantation 
protocol of pure human HSCs into zebrafish larvae. Human 
PBMCs were enriched for CD34 cells and further purified by 
cell sorting using the HSC marker CD34. Transplanted of human 
HSCs into 52hpf larvae was achieved by injection into the Duct 
of Cuvier. We have evidence that human HSCs home to the 
zebrafish CHT, where they interact with endothelial cells and 
undergo cell division. This conserved engraftment mechanism 
makes zebrafish a unique model to study HSC engraftment and 
we wish to highlight the significant opportunities to impact on 
reductions in mammalian model usage. This could lead to new 
clinical applications to improve the speed and extent of human 
HSC engraftment.
Humanised zebrafish could offer a welfare improvement 
compared to current mouse models, as early zebrafish larvae do 
not require immunodepletion by irradiation or multiple genetic 
modifications to avoid graft rejection. Zebrafish do not 
develop functional adaptive immunity until 2 weeks of age and 
therefore do not require severe procedures if the transplanta-
tion occurs in this time window (Langenau et al., 2004). Using 
a model with substantially reduced risk of fatal infection and 
eliminating the need for irradiation significantly refines the 
current substantial severity protocols.
Additionally, upon transplantation of human stem cells, mice 
must be grown for several months to assess engraftment success 
by analysing the reconstitution of the immune system. The trans-
parency of the zebrafish larvae offers a unique system allow-
ing direct live imaging of transplanted cells to visualise cell 
behaviour and interactions. This will allow the selection of 
only successful engrafted animals for further analysis and will 
therefore improve experimental design and throughput whilst 
simultaneously reducing animal numbers.
Moreover, humanised mice are still being used to optimise 
protocols of HSCs transplantation, such as source, type and 
number of cells transplanted and testing different expansion 
protocol (Tanner et al., 2014). High-throughput assays can easily 
be performed using zebrafish larvae, with the scientific advan-
tage of generating a broader range of outputs at lower cost. 
This, combined with transparency of the larvae to quickly assess 
engraftment, we expect that our model may be used to replace 
the use of mouse models during these optimisation phases. 
Mammalian models could then be reserved purely for the 
analysis required by law before clinical trials are performed. This 
could replace all the murine models currently used to optimise 
protocols with zebrafish larvae before the onset of independent 
feeding – considered in law and ethics as a model of significantly 
lower neurophysiological sensitivity.
Finally, humanised mice used to study human stem cell trans-
plantation require an average of 1×105 CD34+ cells per animal. 
100ml of blood yields approximately 1×108 peripheral blood 
mononuclear cells (PBMCs) from which 0.1%, or 1×105 
CD34+ cells are routinely isolated, enough for just one mouse. 
However, we have demonstrated that zebrafish larvae only 
need 20 to 50 cells transplanted to successfully engraft. Thus, 
replacing mouse models by a smaller non-protected vertebrate 
will allow testing of multiple conditions into multiple animals 
from the same human donor. This will decrease natural variations 
therefore improving reproducibility and reliability of research 
performed in this field.
Methods
A detailed protocol of the procedure is available in Supplementary 
File 1.
Zebrafish husbandry
Zebrafish (Danio Rerio) were raised and maintained under the 
Animal [Scientific Procedures] Act 1986 (Home Office Project 
Licence 70/8178 used to raise and maintain transgenic lines) 
using standard protocols (Nüsslein-Volhard & Dham, 2002). 
Zebrafish adults were hosted in UK Home Office-approved aquaria 
at the Bateson Centre, University of Sheffield, and kept under a 
14/10 light/dark regime at 28 degrees. The endothelial cells 
transgenic reporter line Tg(kdrl:HRAS-mCherry-CAAX) (allele 
code s916) (Chi et al., 2008) is referred to as kdrl:mCherry in the 
manuscript.
Human PBMCs collection and HSCs enrichment
Blood was taken from healthy volunteers (pool of 9 donors, 
males and females, aged between 18 and 40) with written 
informed consent and ethical approval from the South Sheffield 
Research Ethics Committee (STH18729). Human PBMCs 
were collected after routine neutrophil preparation by dextran 
sedimentation followed by plasma-Percoll gradient centrifu-
gation from whole blood (Prince et al., 2017). PBMCs were 
further purified by positive selection using the CD34 MicroBead 
kit (Miltenyl Biotech, Bergisch Gladbach, Germany).
CD34 cell sorting of Human HSCs
CD34 enriched PBMCs were labelled with anti-Human 
CD34-eFluor450 antibody (eBioscience- RRID:AB_10734946) 
and positive cells were sorted using Fluorescence Activated 
Cell Sorting (FACS). Sorted cells were labelled with Fluorescein 
and injected into the Duct of Cuvier in 52hpf zebrafish.
Microscopy
Zebrafish larvae were sedated in Tricaine and embedded in 
0.8% low melting point agarose. High-resolution imaging was 
performed using a Spinning Disk confocal microscope.
Statistical analysis
Sample size (n=10) is represented by number of larvae used to 
count human HSCs present in the CHT or within perivascular 
pockets. Paired T-test was used to assess significance using 
free GraphPad software online.
Results
Human CD34 cells can be purified from human whole 
blood
In human stem transplantation therapy, successful transplanta-
tion correlates with high number of injected CD34 positive cells 
(Zaucha et al., 2001). To produce a population of human 
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cells that would mimic a human HSC graft, we used the CD34 
marker to purify HSC from whole blood. The method, summa-
rised in Figure 1 and detailed in Supplementary File 1, consists of 
multiple steps in order to ensure robust and consistent 
purification of CD34 cells. Whole blood was collected from 
healthy volunteers and immediately processed to extract 
neutrophils and PBMCs. The PBMC fraction was then enriched 
for CD34 cells using a positive selection magnetic column. 
These cells were then further labelled with a human anti- 
CD34eFluor450 antibody and sorted using FACS. Only cells 
positive for the eFluor450 fluorophore were sorted; therefore 
ensuring a pure CD34 cell population (Figure 2).
Figure 1. Diagram of our protocol: How to purify human CD34 cells from whole blood and transplant into zebrafish. Whole blood 
preparation by Percoll gradient allowed us to separate peripheral blood mononuclear cells (PBMCs) from neutrophils and red blood cells 
(RBCs). PBMCs were enriched for CD34 cells using a positive selection magnetic column. A pure CD34 cell population was sorted using a 
human anti-CD34eFLuor450 antibody by FACS. CD34 cells were labelled using luorescein and injected into the Duct of Cuvier of 52 hour post 
fertilisation zebraish larvae. Animal with human cells in their CHT were selected for further high-resolution imaging.
Figure 2. Anti-CD34 antibody staining identifies a clear cell population in CD34 enriched cells by flow cytometry. (A) Healthy cells only 
were gated to analyse luorescence. (B) A clear cell population (black rectangle) of small cells was positive for the Violet450 luorophore as 
determined by the no antibody control (C) where that same cell population is shifted to the left of the X-axis.
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CD34 cells represent a small fraction of PBMCs. During each 
experiment, cells were counted at each specific point of the 
protocol and expected ranges of cells have also been noted on 
the protocol. The volume of blood taken varied between 50ml 
and 180ml (left axis Figure 3). Cell number was counted on 
a haemocytometer after each important step of the protocol. 
Number of cells after PBMCs isolation varied between 83 and 
162.5 millions, and after red blood cell (RBC) lysis numbers 
ranged from 50.6 and 149.6 millions. Of note, our results show 
no significant difference in PBMC number after RBC lysis 
(Figure 3, n=14). After CD34 enrichment, cells were counted 
again and varied between 0.152 and 6.15 millions. Finally, 
after cell sorting, we recorded a range of pure CD34 cells 
between 3000 and 100,000. As expected, as the purity of 
CD34 cells increased, the cell number dramatically decreased 
(Figure 3). On average, CD34 positive cells represented 0.033% 
of total PBMCs recovered from the cell preparation (n=10). 
Moreover, paired Pearson correlation analysis was performed 
between the blood volume taken and the final number of sorted 
CD34 cells and no correlation was found (p= 0.115, n=14, Pearson 
r=0.441). This may be due to the high variability in the pool of 
CD34 cells between donors.
Injected human CD34 cells adhere to the zebrafish CHT. 
Purified human CD34 cells were labelled with fluorescein and 
injected into the blood circulation by targeting the Duct of 
Cuvier in 52hpf zebrafish larvae (Figure 1). We first observed 
that human CD34 cells are visible in the zebrafish CHT immedi-
ately after injection (Figure 4A) where they appeared to adhere 
to the endothelial wall of the blood vessels forming the CHT. 
Subsequently, instead of being washed away from the CHT 
by the blood flow, human CD34 cells were seen to roll and 
tether along the caudal vein. This behaviour has previously been 
reported for endogenous zebrafish HSCs, known to emerge from 
the ventral wall of aorta to join the circulation and roll along 
the endothelium of the caudal vein to reach their haematopoi-
etic niche (Gering & Patient, 2005; Kissa & Herbomel, 2010; 
Tamplin et al., 2015). We observed that 100% of injected 
human CD34 cells initially adhere to the wall of the caudal vein 
in the CHT within one hour after injection (Figure 4B). Imaging 
12 hours later showed that only 50% of these cells are still 
present in the CHT (Figure 4C).
Human CD34 cells engraft in zebrafish haematopoietic niches. 
It is known that zebrafish and mouse HSCs, once adhered to 
the caudal vein, enter perivascular pockets proximally to the 
caudal vein (Figure 5A, white arrowheads) (Kiel et al., 2005; 
Nombela-Arrieta et al., 2013; Tamplin et al., 2015). To assess 
whether human CD34 cells interact with zebrafish endothe-
lial cells, we transplanted CD34 human cells into the Tg(kdrl:
mCherry) reporter line labelling endothelial cells in red 
(Chi et al., 2008). Spinning disk confocal images focusing on 
the zebrafish CHT showed that at 2 hours post transplantation 
(hpt) human CD34 cells are still in the caudal vein (Figure 5A). 
At 9hpt, we observed co-localisation of human CD34 cells 
with endothelial cells, with some human CD34 cells already 
inside the perivascular pockets (Figure 5A). Once inside the 
perivascular pocket, we observed interactions with endothe-
lial cells within the pocket, this process has already been 
termed ‘cuddling’ when imaging endogenous zebrafish HSCs: 
endothelial cells surround and embrace the incoming stem cell 
(Tamplin et al., 2015). Clear extensions, positive for the endothe-
lial cell marker, were observed surrounding a human CD34 cell 
from within the perivascular pocket (Figure 5B, Supplementary 
Movie 1). Moreover, we imaged an instance where human 
CD34 cells divide within the zebrafish haematopoietic niche 
Figure 3. CD34 cells represent a small fraction of PBMCs. Left scale represent the blood volume taken per donors. Paired T-test was used 
to analyse statistical signiicance between ‘after blood prep group’ and ‘after red blood cell (RBC) lysis group’ (n=10).
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Figure 4. Injected human CD34 cells quickly appear in the zebrafish Caudal Haematopoietic Tissue (CHT). (A) Stitched Z-stack of whole 
Zebraish larvae trunk highlighting the CHT (white rectangle). (B) Representative Z-Stack images of luorescein labelled human CD34 cells 
present at the CHT at 1hour post transplantation (hpt), 5hpt, 9hpt and 13hpt. Scale bar=80μm. (C) Quantiication of cells in the CHT versus 
circulating cells in 5 larvae injected with luorescein labelled human CD34 cells (n=5).
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Figure 5. Human CD34 cells interact with zebrafish endothelial cells. Spinning disk confocal stills of timelapses zebraish Caudal 
Haematopoietic Tissue (white lines) from the endothelial cell (red) reporter line Tg(kdrl:mCherry) zebraish larvae transplanted with human 
CD34 cells (green). (A) At 2hpt, human CD34 cells are still in the vessels and empty perivascular pockets (white arrowheads) do not contain 
human CD34 cells. At 9hpt, human CD34 cells co-localised with endothelial cells and human CD34 cells appears inside the perivascular 
pockets (white arrows). DA: Dorsal aorta, CV: Caudal vein. Scale bar= 50μm. (B) High magniication of a human CD34 cell being ‘cuddled’ 
by surrounding endothelial cells, note the endothelial cell protrusion acting like arms (white arrows). Scale bar= 50μm. (C) Division of a 
human CD34 cells (white arrow) within a perivascular pocket, with hpt displayed. Note the equal distribution of luorescence between the two 
daughter cells in the last frame. Scale bar=10μm.
(Figure 5C, Supplementary Movie 2). These observations 
showed that these human CD34 cells have engrafted into the 
zebrafish CHT, therefore confirming that the zebrafish native 
CHT provides a human-compatible environment to allow human 
cells to engraft.
Dataset 1. FACS output files for Figure 2
http://dx.doi.org/10.5256/f1000research.14507.d200844
Dataset 2. Raw values file for Figure 3
http://dx.doi.org/10.5256/f1000research.14507.d200845
Dataset 3. Raw values file and image file for Figure 4
http://dx.doi.org/10.5256/f1000research.14507.d200847




Our protocol of human HSCs transplantation in zebrafish 
resulted in similar events observed in the numerous studies on 
zebrafish haematopoiesis. Zebrafish haematopoiesis has been 
well described and it is known that endogenous HSCs emerge 
from the ventral wall of aorta to join the circulation at around 
36 hours post fertilisation (Gering & Patient, 2005; Kissa 
& Herbomel, 2010). HSCs roll along the endothelium of the 
caudal vein in the zebrafish CHT, where they exit the blood 
vessel to reach perivascular pockets of endothelial cells (Gering 
& Patient, 2005; Kissa & Herbomel, 2010; Tamplin et al., 2015). 
This haematopoietic niche protects the stem cell and allows it to 
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divide and colonise other haematopoietic tissues. The well- 
described engraftment process of zebrafish HSCs in the CHT 
has provided us with key cell engraftment behaviour to look for.
Indeed, we have observed that human CD34 cells home into 
the zebrafish CHT, where they engage with endothelial cells. 
By using high resolution confocal microscopy on transplanted 
zebrafish from the Tg(kdrl:mCherry) endothelial cells reporter 
line, we observed that human CD34 cells exit the caudal vein 
to reach perivascular pockets of endothelial cells within 9 hours 
after injection. Once in perivascular pockets, human CD34+ cells 
are ‘cuddled’ by endothelial cells and even divide, processes 
already described for zebrafish endogenous stem cells.
Future validation assays: Injections of 20 to 50 labelled human 
CD34+ cells in the circulation of zebrafish larvae is enough 
to observe interactions with endothelial cells in perivascular 
pockets and subsequent division within the zebrafish CHT. 
To validate the extent to which this interaction can represent 
engraftment, stem cell colonisation of the definitive haemat-
opoietic organs and further cell differentiation must be studied. 
Stem cell colonisation of the definitive haematopoietic organs 
starts from day 5, the thymus is colonised by HSCs and later 
on the kidney bone marrow, both organs which will con-
tribute to the development of the adaptive immune system 
(Kissa et al., 2008). Future validation assays looking at stem cell 
migration to the thymus and kidneys would be useful to confirm 
the extent of engraftment. Once engrafted, HSCs will produce 
lineage-committed progenitors that will give rise to blood cells, 
including immune cells. To further validate the model, popu-
lations of human blood cells present in adult zebrafish could be 
measured. It was shown that enriched human CD34 cells 
injected into zebrafish larvae resulted in the presence of 
myeloid lineage human cells only (Staal et al., 2016). Our protocol 
using pure CD34 cells may provide a better graft and differentiate 
into multiple lineages.
Limitations of our current protocol: Currently our protocol 
detailed a method for purifying CD34 cells from whole 
blood, known to contain a small number of circulating HSCs. 
Indeed we have shown that blood samples used for cell prepara-
tion contained on average 0.03% of CD34 cells. Our current 
protocol allows the transplantation of 20–50 cells per fish from 
a pool of minimum 10×103 cells, allowing transplantation of 
maximum 100 fish. Although this would be sufficient to assess 
efficiency and viability of a single graft, it would be limiting to 
use as a high-throughput assay. This protocol could be scaled 
up to transplant thousands of zebrafish larvae to perform drug 
screens, or even to apply different HSC markers to study engraft-
ment properties of human HSCs. However, a larger pool of 
HSCs will be required. Parada-Kusz et al described a high- 
throughput transplantation assay of murine CD34 cells from 
bone marrow in zebrafish (Parada-Kusz et al., 2017). Bone 
marrow from crushed femurs contains considerably more CD34 
cells than whole blood, but this source cannot be use for human 
donors. To obtain a larger pool of HSCs, cord blood and enriched 
whole blood after cytokine G-CSF treatment would be suitable 
sources. These samples can be obtained through necessary ethical 
approvals and will provide enough graft material to scale up our 
protocol and perform high-throughput assays.
Translatability: Alongside offering a new model to continue 
research on stem cell transplantation, our zebrafish assay offers 
a scientific advantage that could revolutionise how stem cell 
graft are being tested before transplantation. Currently, most 
patients in need of transplantation receive a graft that has 
been cryopreserved and stored at suprafreezing temperatures 
(Stockschläder et al., 1997). Although these grafts are being tested 
for viability using the Trypan Blue staining, there is currently 
no assay quick enough to test for efficacy of the graft to engraft 
(Fleming & Hubel, 2006). Our data show the potential of human 
CD34+ cells to colonise the haematopoietic niche in zebrafish, 
engraft and proliferate within 9 hours after injection. There-
fore, our zebrafish assay detailed in this study could provide a 
quick, cheap and efficient assay to test graft efficiency and even 
viability in less than 12h.
Transferability: Our zebrafish system to study stem cell trans-
plantation research will also advance the 3Rs components with 
a major impact on animal welfare. The replacement of human-
ised mice by humanised zebrafish larvae will represent a giant 
step for the 3Rs, allowing zebrafish embryos to be a host for 
human stem cells without any myeloablative procedures. The 
refinement of the harmful procedures without the need of myelo-
ablation, by using zebrafish before the development of adaptive 
immunity, represents a powerful alternative to mice. Moreover, 
using a transparent organism before the onset of independent 
feeding to visualise stem cell engraftment will allow selection 
of engrafted animal within 12h. Zebrafish are widely used and 
for communities without zebrafish facilities, a small zebrafish 
system to host the few adults needed for this experiment is easy 
and cheap to start. These critical advantages of this assay using 
zebrafish as a model system will, we hope, increase the chances 
of wide uptake of this system.
Data availability
Dataset 1: FACS output files for Figure 2. DOI: 10.5256/
f1000research.14507.d200844 (Hamilton et al., 2018a)
Dataset 2: Raw values file for Figure 3. DOI: 10.5256/
f1000research.14507.d200845 (Hamilton et al., 2018b)
Dataset 3: Raw values file and image file for Figure 4. DOI: 
10.5256/f1000research.14507.d200847 (Hamilton et al., 2018c)
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Dataset 4: Raw image file for Figure 5. Images should be opened 
with Velocity software. DOI: 10.5256/f1000research.14507.
d200848 (Hamilton et al., 2018d)
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